Theranexus (EPA:ALTHX)

BRIEF

published on 01/16/2025 at 18:05, 1 year 3 months ago

Theranexus: Monthly update of voting rights and shares

Voting Rights Actions Stock Market Biopharmaceutical Theranexus
BRIEF

published on 01/09/2025 at 18:05, 1 year 3 months ago

Theranexus Publishes its Letter to Shareholders

Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform
PRESS RELEASE

published on 01/09/2025 at 18:00, 1 year 3 months ago

THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS
Theranexus, an innovative biopharmaceutical company, announces the publication of its letter to shareholders. Shareholders can download the newsletter from the company website

Shareholders Biopharmaceutical Newsletter Theranexus Neurological Diseases
BRIEF

published on 12/17/2024 at 18:20, 1 year 4 months ago

Theranexus optimizes its cash flow and extends its financial horizon

Treasury Funding License Agreement Theranexus Batten Disease
PRESS RELEASE

published on 12/17/2024 at 18:15, 1 year 4 months ago

THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON
Theranexus presents an update of its cash position and cash flow horizon, expecting improvement through upcoming payments and restructuring agreement with banking partners

Cash Position Cash Flow Financial Debt Theranexus Banking Partners
BRIEF

published on 12/17/2024 at 18:05, 1 year 4 months ago

License agreement between Theranexus and Exeltis for TX01

Rare Diseases License Agreement Theranexus Exeltis TX01
PRESS RELEASE

published on 12/17/2024 at 18:00, 1 year 4 months ago

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS
Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions

License Agreement Theranexus Neurological Diseases Exeltis TX01
BRIEF

published on 11/19/2024 at 18:05, 1 year 5 months ago

Theranexus presents positive results for the treatment of Batten disease CLN3

Clinical Trial Theranexus Batten-1 Batten Disease Visual Acuity
PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 5 months ago

Update on the Theranexus' Batten-1 project in CLN3 Batten's disease
Theranexus and BBDF present positive results of Batten-1 trial in CLN3 Batten disease patients, showing safety and efficacy of miglustat. Expanded use indicates potential in visual acuity stabilization

Theranexus BBDF Batten-1 Trial CLN3 Batten Disease Miglustat
BRIEF

published on 10/23/2024 at 18:05, 1 year 6 months ago

Theranexus Announces Its Cash Position as of September 30, 2024

Treasury Batten Disease Miglustat Research Tax Credit Industrial Partnerships

Published on 05/02/2026 at 21:00, 22 hours 55 minutes ago

GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 18 hours ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 19 hours ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 19 hours ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 19 hours ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

View all ACCESSWIRE

Published on 05/03/2026 at 04:45, 15 hours 9 minutes ago

GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 4 hours ago

Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 2 days ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 2 days 1 hour ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 2 days 2 hours ago

Key Figures 30.04.2026

View all EQS

Published on 04/30/2026 at 20:00, 2 days 23 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 3 days ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 days ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 3 days 1 hour ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 3 days 1 hour ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News